Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy
- PMID: 8385540
- DOI: 10.1016/0006-8993(93)91368-3
Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy
Abstract
The therapeutic effects of dextrorphan and ketamine, two non-competitive N-methyl-D-aspartate (NMDA) receptor antagonists, on neuropathic pain-related behaviors were examined in rats with peripheral mononeuropathy induced by loose ligation of the common sciatic nerve (chronic constrictive injury, CCI). Four daily intrathecal treatments (beginning 1 h after nerve ligation) with dextrorphan or ketamine (12.5-100 nmol) reliably attenuated hyperalgesia to radiant heat and spontaneous pain-related behaviors in CCI rats. Thermal hyperalgesia also was reduced in CCI rats receiving a single intrathecal treatment with either dextrorphan or ketamine (50 and 100 nmol for each compound) on day 3 after nerve ligation when thermal hyperalgesia was well developed. Since both dextrorphan and ketamine are currently utilized in other clinical applications, the results suggest a new therapeutic utility of these 'old' compounds in treatment of neuropathic pain syndromes resulting from peripheral nerve injury.
Similar articles
-
Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral mononeuropathy.Brain Res. 1992 Dec 11;598(1-2):271-8. doi: 10.1016/0006-8993(92)90193-d. Brain Res. 1992. PMID: 1362520
-
Intrathecal GM1 ganglioside and local nerve anesthesia reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy.Brain Res. 1992 Jul 3;584(1-2):28-53. doi: 10.1016/0006-8993(92)90874-9. Brain Res. 1992. PMID: 1325247
-
Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy.Brain Res. 1992 Apr 3;576(2):254-62. doi: 10.1016/0006-8993(92)90688-6. Brain Res. 1992. PMID: 1325239
-
Dextrorphan relieves neuropathic heat-evoked hyperalgesia in the rat.Neurosci Lett. 1993 Mar 5;151(1):107-10. doi: 10.1016/0304-3940(93)90058-s. Neurosci Lett. 1993. PMID: 8385757
-
[Animal models of neuropathic pain].Nihon Yakurigaku Zasshi. 2006 Mar;127(3):151-5, 146. doi: 10.1254/fpj.127.151. Nihon Yakurigaku Zasshi. 2006. PMID: 16651794 Review. Japanese. No abstract available.
Cited by
-
The Epidural and Intrathecal Administration of Ketamine.Curr Rev Pain. 1999;3(6):458-472. doi: 10.1007/s11916-999-0074-1. Curr Rev Pain. 1999. PMID: 10998705
-
Impaired NMDA receptor-mediated postsynaptic function and blunted NMDA receptor-dependent persistent pain in mice lacking postsynaptic density-93 protein.J Neurosci. 2003 Jul 30;23(17):6703-12. doi: 10.1523/JNEUROSCI.23-17-06703.2003. J Neurosci. 2003. PMID: 12890763 Free PMC article.
-
An isobolographic analysis of the effects of N-methyl-D-aspartate and NK1 tachykinin receptor antagonists on inflammatory hyperalgesia in the rat.Br J Pharmacol. 1996 Jan;117(1):196-202. doi: 10.1111/j.1476-5381.1996.tb15174.x. Br J Pharmacol. 1996. PMID: 8825363 Free PMC article.
-
NMDA Receptors at Primary Afferent-Excitatory Neuron Synapses Differentially Sustain Chemotherapy- and Nerve Trauma-Induced Chronic Pain.J Neurosci. 2023 May 24;43(21):3933-3948. doi: 10.1523/JNEUROSCI.0183-23.2023. Epub 2023 Apr 26. J Neurosci. 2023. PMID: 37185237 Free PMC article.
-
Effect of ketamine combined with magnesium sulfate in neuropathic pain patients (KETAPAIN): study protocol for a randomized controlled trial.Trials. 2017 Nov 3;18(1):517. doi: 10.1186/s13063-017-2254-3. Trials. 2017. PMID: 29100524 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
